Compare WPP & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WPP | AMRX |
|---|---|---|
| Founded | 1985 | 2002 |
| Country | United Kingdom | United States |
| Employees | 104000 | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | 2018 |
| Metric | WPP | AMRX |
|---|---|---|
| Price | $16.76 | $12.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | N/A | ★ $14.75 |
| AVG Volume (30 Days) | 711.2K | ★ 1.6M |
| Earning Date | 04-24-2026 | 05-01-2026 |
| Dividend Yield | ★ 12.77% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | $4.33 | $7.13 |
| P/E Ratio | ★ $38.96 | $58.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.81 | $7.01 |
| 52 Week High | $40.95 | $15.42 |
| Indicator | WPP | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 47.03 |
| Support Level | $15.89 | $11.60 |
| Resistance Level | $19.55 | $12.85 |
| Average True Range (ATR) | 0.46 | 0.32 |
| MACD | 0.28 | 0.12 |
| Stochastic Oscillator | 68.68 | 61.38 |
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.